Quantitation of N,N,N',N'-tetrakis (2-hydroxypropyl)-ethylenediamine in plasma by gas chromatography

A wide-bore capillary gas chromatographic method with nitrogen-selective thermionic detection is described for the quantitative analysis of N,N,N',N'-tetrakis (2-hydroxypropyl)ethylenediamine (Quadrol) in plasma. N,N,N',N'-tetrakis (2-hydroxybutyl)ethylenediamine is used as an internal standard. Rat or human plasma samples (0.5 ml) are mixed with internal standard, adjusted to alkaline pH and subjected to a single extraction with dichloromethane. Quadrol recovery from plasma typically exceeds 90%. The method is linear over the range 1.0-50 micrograms/ml. The working detection limit is 0.5 microgram/ml and the analysis time is under 7 min. The procedure has been used to obtain plasma concentration versus time data for the evaluation of Quadrol pharmacokinetics in rats.     

Determination of famotidine in low-volume human plasma by normal-phase liquid chromatography/tandem mass spectrometry

A rapid, sensitive and robust assay procedure using liquid chromatography coupled with tandem mass spectrometry (LC/MS/MS) for the determination of famotidine in human plasma and urine is described. Famotidine and the internal standard were isolated from plasma samples by cation-exchange solid-phase extraction with benzenesulfonic acid (SCX) cartridges. The urine assay used direct injection of a diluted urine sample. The chromatographic separation was accomplished by using a BDS Hypersil silica column with a mobile phase of acetonitrile-water containing trifluoroacetic acid. The MS/MS detection of the analytes was set in the positive ionization mode using electrospray ionization for sample introduction. The analyte and internal standard precursor-product ion combinations were monitored in the multiple-reaction monitoring mode. Assay calibration curves were linear in the concentration range 0.5--500 ng ml(-1) and 0.05--50 microg ml(-1) in plasma and urine, respectively. For the plasma assay, a 100 microl sample aliquot was subjected to extraction. To perform the urine assay, a 50 microl sample aliquot was used. The intra-day relative standard deviations at all concentration levels were <10%. The inter-day consistency was assessed by running quality control samples during each daily run. The limit of quantification was 0.5 ng ml(-1) in plasma and 0.05 microg ml(-1) in urine. The methods were utilized to support clinical pharmacokinetic studies in infants aged 0-12 months.     

Development of an LC/MS method for the trace analysis of triacetone triperoxide (TATP)

The detection and quantification of triacetone triperoxide (TATP) using LC/MS is investigated. GC/MS analysis of TATP is hindered by stationary phase activation in very short periods of time. Due to the lower temperatures used in LC. this problem is not encountered. This study presents a method that is suitable for the detection of TATP at levels as low as 100 pg microl(-1) (10 ng per 100 microl). Initial findings are also reported for the investigation of a secondary chromatographic peak, which is thought to be caused by separation of two conformers. This study concludes that LC/MS is a suitable technique for the analysis of trace levels of TATP.     

Synthesis and structural investigation of N,N',N' '-trialkylguanidinato-supported zirconium(IV) complexes

The addition of 2 equiv of N,N',N' '-triisopropylguanidine (guanH(2)) to Zr(CH(2)Ph)(4) produced the bis(guanidinato)bis(benzyl)zirconium complex [((i)PrNH)C(N(i)Pr)(2)](2)Zr(CH(2)Ph)(2) (1). The mono(guanidinato) complex [((i)PrN)(2)C(NH(i)Pr)]ZrCl(3) (2) was accessible by the reaction of 2 equiv of guanH(2) with ZrCl(4). Guanidinium hydrochloride, [C(NH(i)Pr)(3)]Cl, is a byproduct of this reaction. When crystallized from THF, complex 2 was isolated as the THF adduct [((i)PrNH)C(N(i)Pr)(2)]ZrCl(3)(THF) (2-THF). The mixed cyclopentadienyl guanidinato complex [eta(5)-1,3-(Me(3)Si)(2)C(5)H(3)][((i)PrNH)C(N(i)Pr)(2)]ZrCl(2) (3) was prepared by treatment of [1,3-(Me(3)Si)(2)C(5)H(3)]ZrCl(3) with the in situ generated lithium triisopropylguanidinate salt. The reaction of guanH(2) with [1,3-(Me(3)Si)(2)C(5)H(3)]ZrMe(3) affords the dimethyl derivative [eta(5)-1,3-(Me(3)Si)(2)C(5)H(3)][((i)PrNH)C(N(i)Pr)(2)]ZrMe(2) (4). Definitive evidence for the molecular structures of these products is provided through single-crystal X-ray characterization of 1, 2-THF, and 3, which are presented. The extent of pi delocalization within the guanidinato ligand is discussed in the context of the metrical parameters obtained from these structural studies.     

Oligodentate P,N ligands: N,N,N',N'-tetrakis(diphenylphosphanyl)-1,3-diaminobenzene complexes of rhodium, nickel and palladium

The oligodentate P,N ligand N,N,N',N'-tetrakis(diphenylphosphanyl)-1,3-diaminobenzene reacts with two equivalents of [{Rh(mu-Cl)(COD)}(2)], [NiBr(2)(DME)] or [PdCl(2)(NCMe)(2)](COD = 1,5-cyclooctadiene, DME = dimethoxyethane) in dichloromethane to give the tetranuclear complex [1,3-{cis-Rh(COD)(mu-Cl)(2)Rh(PPh(2))(2)N}(2)C(6)H(4)](1) or the dinuclear complexes [1,3-{cis-NiBr(2)(PPh(2))(2)N}(2)C(6)H(4)](2) and [1,3-{cis-PdCl(2)(PPh(2))(2)N}(2)C(6)H(4)](3), respectively. Compounds 1-3 were characterised by NMR ((1)H, (13)C, (31)P) and IR spectroscopy. The molecular structure of 2 and 3 shows the formation of a bis-chelate complex with M-P-N-P four-membered rings (M = Pd, Ni). An N,N,N',N'-tetrakis(diphenylphosphanyl)-1,3-diaminobenzene/Pd(OAc)(2) mixture was used for the copolymerisation of carbon monoxide with ethene or ethylidenenorbornene. Compound 1 was employed as catalyst in the hydrogenation of styrene.     

The pK(a) values of N,N,N',N'-tetrakis-(2-hydroxypropyl)ethylenediamine

Aqueous solutions of the industrially important chelating agent N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine exhibit basic properties. The proton dissociation constants were determined to be 8.99 +/- 0.04 (pK(1)) and 4.30 +/- 0.04 (pK(2)) by potentiometric titration at 25 degrees in 0.15M sodium chloride.     

Simultaneous determination of metformin and gliclazide in human plasma by liquid chromatography-tandem mass spectrometry: application to a bioequivalence study of two formulations in healthy volunteers

A rapid and sensitive liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and validated to simultaneously determine gliclazide and metformin in human plasma using huperzine A as the internal standard (IS). After acetonitrile-induced protein precipitation of the plasma samples, gliclazide, metformin and the IS were subjected to LC/MS/MS analysis using electro-spray ionization (ESI). Chromatographic separation was performed on a Hypersil BDS C18 column (50 mm x 2.1 mm, i.d., 3 microm). The method had a chromatographic running time of 2.0 min and linear calibration curves over the concentration ranges of 10-10,000 ng ml(-1) for gliclazide and 7.8-4678.9 ng ml(-1) for metformin. The recoveries of the method were found to be 71-104%. The lower limits of quantification (LOQ) of the method were 10.0 and 7.8 ng ml(-1) for gliclazide and metformin, respectively. The intra- and interday precision was less than 15% for all quality control samples at concentrations of 100, 500, and 2000 ng ml(-1). The validated LC/MS/MS method has been used to study bioequivalence in healthy volunteers. These results indicate that the method was efficient with a very short running time (2.0 min) for metformin and gliclazide compared to the methods reported in the literature. The presented method had acceptable accuracy, precision and sensitivity and was used in clinical bioequivalence study.     

Radiolysis of cobalt(III)-1,2 bis(beta-aminoethoxy)ethane N,N,N',N' sodium sulfonate triacetic acid chelate

Chelation studies of cobalt(III) with 1,2 bis(beta-aminoethoxy)ethane N,N,N',N' sodium sulfonate triacetic acid (ASTA) were performed. The results showed the effectiveness of ASTA as a chelating agent by using: molar ratio, continuous variation and slope ratio methods. Stable complex 1∶1 was formed at pH from 6.0 to 10.5. Solutions of Co-ASTA chelate of different molar ratios at pH 6.5 and 8.0 were irradiated by different gamma-radiation doses. The results showed a linear decrease of absorbance with gamma-radiation dose which can be utilized as a dosimeter for low dose rate measurement in the range studied. A proposed radiolytic mechanism is discussed. The degradation of the ASTA ligand has been related to hydroxyl radical attack.     

Highly cross-linked polymers containing N,N',N' '-chelate ligands for the Cu(II)-mediated hydrolysis of phosphoesters

Three immobilized Cu(II) complexes were generated by the following: (a) homopolymerization of the N,N',N' '-chelate ligand tris[2-(1-vinylimidazolyl)]phosphine (1) and subsequent metalation with CuCl2; (b) copolymerization of 1 with ethyleneglycol dimethacrylate (EGDMA) und subsequent metalation with CuCl2; or (c) molecular imprinting with the organometallic Mo-complex [Mo(eta3-C4H7)(CO)2(1)](TsO) (5) and EGDMA and subsequent replacement of Mo(II) by Cu(II). All three polymeric Cu complexes were found to efficiently promote the hydrolysis of activated phosphoesters with the relative activity being dependent on the nature of the polymer and the substrate.     

Quantification of cyclophosphamide and its metabolites in urine using liquid chromatography/tandem mass spectrometry

A reliable and easy to use liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed for the simultaneous quantification of urinary concentrations of cyclophosphamide (CP) and its main metabolites excreted in urine, i.e. N-dechloroethylcyclophosphamide (DCL-CP), 4-ketocyclophosphamide (4KetoCP), and carboxyphosphamide (CarboxyCP). Sample preparation consisted of dilution of urine with an aqueous solution of the internal standard D(4)-CP and methanol, and centrifugation. LC/MS/MS detection was performed using a triple-quadrupole mass spectrometer working in selected reaction monitoring mode. All analytes were quantified in a single run within 11.5 min. The limits of detection were 5 ng/mL for CP and 4KetoCP, 1 ng/mL for DCL-CP, and 30 ng/mL for CarboxyCP. Quantification ranges were adjusted to the expected concentrations in 24-h urine collections of patients treated with a polychemotherapy regimen (3-175 microg/mL for CP, 0.5-27 microg/mL for 4KetoCP and 0.17-9 microg/mL for CarboxyCP and DCL-CP, respectively). The method was validated according to international guidelines of the ICH and the FDA.     

Development of a gas chromatographic/mass spectrometric method to quantify R(-)-apomorphine, R(-)-apocodeine and R(-)-norapomorphine in human plasma and urine

A method was developed and validated for the analysis of R(-)-apomorphine, (R-)-apocodeine and R(-)-norapomorphine in human plasma and urine with N-propylnorapomorphine as internal standard using gas chromatography/mass spectrometry (GC/MS) and single-ion monitoring after a single liquid-liquid extraction and silylation of compounds. The quantification limits were 1 ng/ml for apomorphine and apocodeine and 25 ng/ml for norapomorphine. Calibration curves were linear, within the range 1-100 ng/ml. Variation in intraday and interday precision was below 10%. This method was applied to study apomorphine bioavailability in nine patients with Parkinson's disease before and after coadministration of a catechol-O-methyl transferase inhibitor.     

Copper(II) complexes of tridentate N,N,N',N',N'-pentamethyldiethylenetriamine: superoxide dismutase and inhibitory activity against bacteria and fungi

A series of ternary copper(II) complexes containing same coordination sphere but difference in the counter ions, viz., [Cu(PMDT)(OAc)]PF(6)(1); [Cu(PMDT)(OAc)]ClO(4)(2); [Cu(PMDT)(OAc)]BF(4)(3) and [Cu(PMDT)(OAc)]BPh(4)(4) where PMDT=N,N,N',N',N'-pentamethyldiethylenetriamine, OAc=Acetate ion were synthesized and characterized by means of spectroscopic, magnetic and cyclic voltammetric measurements. In frozen solution e.p.r. spectra, an interesting relation g|| >g(perpendicular) has been observed which is atypical of the axially symmetric d(9) Cu(II) (S(Cu)=1/2) having an unpaired electron in a d (x2-y2) orbital. Single crystal X-ray analysis of (1) has revealed the presence of distorted square planar geometry. The influence of the counter ion on the complexes has been examined by performing some biological experiments like superoxide dismutase and anti-microbial activity.     

Simultaneous determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy- Delta9-tetrahydrocannabinol in human plasma by high-performance liquid chromatography/tandem mass spectrometry

A rapid and sensitive method for the simultaneous confirmatory analysis of three forensic most relevant cannabinoids, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-Delta(9)-tetrahydrocannabinol (11-OH-THC) and 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol (THC-COOH), by means of high-performance liquid chromatography/tandem mass spectrometry (LC/MS/MS) in human plasma was developed and fully validated. Sample clean-up was performed by automated silica-based solid-phase extraction and the separation was carried out using a PhenylHexyl column (50 x 2 mm i.d., 3 micro m) and acetonitrile-5 mM ammonium acetate gradient elution. Data were acquired with an API 3000 LC/MS/MS system equipped with a turboionspray interface and triple quadrupole mass analyzer using positive electrospray ionization and multiple reaction monitoring. Two MS/MS transitions for each substance were monitored and deuterated analogues of analytes were used as internal standards for quantitation. The limit of quantitation was 0.8 ng ml(-1) for THC, 0.8 ng ml(-1) for 11-OH-THC and 4.3 ng ml(-1) for THC-COOH and linearity with a correlation coefficient r(2) = 0.999 was achieved up to 100 ng ml(-1) for THC and 11-OH-THC and 500 ng ml(-1) for THC-COOH. The limits of detection were 0.2 ng ml(-1) for THC, 0.2 ng ml(-1) for 11-OH-THC and 1.6 ng ml(-1) for THC-COOH. The developed LC/MS/MS method was also successfully used for the determination of THC-COOH-glucuronide, the phase II metabolite of THC-COOH.     

Potentiometric behavior of N,N,N',N'-tetrabenzylmethylenediamine-based hydrogen ion-selective electrodes

H(+)-ion selective electrodes (H(+)-ISE) based on N,N,N',N'-tetrabenzylalkylenediamine (alkylene: methylene, ethylene, propylene, hexylene) are prepared. We are compared with their response potentials to carbon numbers between diamino groups. They were showed linear selective to hydrogen ion in the range of pH 1.5-9.0, 2.5-9.0, 3.5-9.0 and 4.0-9.0, and their Nernstian slopes were 57.3, 53.5, 57.4 and 56.1 mV pH(-1) at 20+/-0.2 degrees C (theoretical value: 58.2 mV pH(-1)), respectively. The interference effect on the cations were measured to alkali metal ions, alkaline earth metals ions. Selectivity coefficients were measured by the mixed-solution method. Among all electrodes the N,N,N',N'-tetrabenzylmethylenediamine (TBMDA)-based electrode has shown the best selectivity in acidic solution.     

Interaction of immunoglobulin G with N,N,N',N'-ethylenediaminetetramethylenephosphonic acid-modified zirconia

Zirconia beads (25-38 microm in diameter) were modified with N,N,N'.N'-ethylenediaminetetramethylenephosphonic acid to generate a pseudo-biospecific support, r_PEZ. To better understand the force of interaction between the IgG and the r_PEZ, the equilibrium dissociation constant (Kd) was determined by static binding isotherms, as a function of temperature and by frontal analysis at different linear velocities. Temperature had no significant impact on the maximum static binding capacity (Q(max)) and the equilibrium-binding constant (Kd), whereas pH and the salt concentration had a noticeable impact on both Q(max) and Kd values. Q(max) was found to be in the range of 55-65 mg IgG per ml of beads and unaffected by temperature. The maximum dynamic binding capacity (Qx) was found to be in the range of 20-12 mg IgG per ml of beads. The adsorption rate constant (ka) was determined by a split-peak approach to be between 982 and 32421 mol(-1) s(-1) depending on the linear velocity. Adsorption rate of IgG on r_PEZ was studied as a function of both feed concentration and linear velocity. The standard enthalpy and entropy values were estimated for the interaction of IgG with this novel support. The binding constants were also determined by modeling the batch protein-uptake data.     

Speciation of Cr(III) and Cr(VI) and separation of common anions by ion pair chromatography with trans-1,2-diaminecyclohexane-N,N,N',N'-tetraacetic acid

A reversed phase ion pair chromatographic method for the simultaneous determination of Cr species and common anions on a C(18)-bonded stationary phase was developed by using acetonitrile-water (2:98 v/v) containing 1.0 mM tetrabutylammonium hydroxide and 0.5 mM trans-1,2-diaminecyclohexane-N,N,N',N'-tetraacetic acid (DCTA) at pH 6.5 as mobile phase and UV-detection at 210 nm. Chromatographic parameters were optimized for separation of Cr(III)-DCTA complex, chromate and other anions. The detection limits were found as 8 ng/ml for Cr(III) and 35 ng/ml for Cr(VI). Under the optimum conditions, most other ions did not interfere. The method can be applied to separate a number of common anions simultaneously with the separation of Cr(III) and Cr(VI).     

Polarographic investigation of Cu(II) complexes with N,N,N',N'-tetrakis-(2-hydroxypropyl)-ethylenediamine

During investigation of the formation of Cu(2+) ion complexes with N,N,N',N'-tetrakis-(2-hydroxypropyl)-ethylenediamine (Quadrol-Q) by means of constant current polarography (20 degrees C, ionic strength J = 3 mol l(-1)), the possibility of the formation of two complex compounds; CuQ(2+) and CuQ(2+)(2), was shown within the pH range from 6 to 8. The logarithms of the stability constants for these compounds are 10.6 +/- 0.5 and 14.6 +/- 0.4 respectively. Cu(II) complexation increases sharply when the pH increases from 8 to 10. It was shown that the data at a pH of greater than 10 are in accordance with the existence of the hydroxy complexes CuQ(OH)(2) and CuQ(2)(OH)(2), the logarithms of the stability constants being 26.9 +/- 0.5 and 29.1 +/- 0.3.     

Liquid chromatography of lanthanide chelates of 1-(p-nitrophenyl)ethylenediamine-N,N,N',N' -tetra-acetic acid

Preparation of the chelating agent, 1-(p-nitrophenyl)ethylenediamine-N,N,N',N'-tetra-acetic acid (p-nitrophenylEDTA), is described in detail. Separation of p-nitrophenylEDTA chelates of ytterbium(III), erbium(III), dysprosium(III) and europium(III) has been achieved by reversed-phase ion-pair liquid chromatography. With spectrophotometric detection at 254 nm, linear responses over about four orders of magnitude were achieved with detection limits (S/N = 2) of about 0.5 pmole.     

Determination of clindamycin in animal plasma by high-performance liquid chromatography combined with electrospray ionization mass spectrometry

A method for the quantification of clindamycin in animal plasma using high-performance liquid chromatography combined with electrospray ionization mass spectrometry (LC/ESI-MS/MS) is presented. Lincomycin is used as the internal standard. The sample preparation includes a simple deproteinization step with trichloroacetic acid. Chromatographic separation is achieved on an RP-18 Hypersil column using gradient elution with 0.01 M ammonium acetate and acetonitrile as mobile phase. Good linearity was observed in the range 0-10 microg ml(-1). The limit of quantification of the method is 50 ng ml(-1) and the limit of detection is 1.3 ng ml(-1). The method was shown out to be of use for pharmacokinetic studies of clindamycin formulations in dogs.     

Quantitative analysis of the P-glycoprotein inhibitor Elacridar (GF120918) in human and dog plasma using liquid chromatography with tandem mass spectrometric detection

A liquid chromatographic/tandem mass spectrometric (LC/MS/MS) method for the determination of the P-glycoprotein and breast cancer resistance protein inhibitor Elacridar in human and dog plasma is described. The internal standard was stable isotopically labelled Elacridar. Sample pretreatment involved liquid-liquid extraction with tert-butyl methyl ether. Analysis of Elacridar and internal standard was performed by reversed-phase LC on a basic stable minibore analytical column with an eluent consisting of acetonitrile and aqueous ammonia. An API-2000 triple-quadrupole mass spectrometer with an electrospray ion source was used in the positive-ion multiple reaction monitoring mode. The run time per sample was only 6 min. The method is sensitive and specific, with a dynamic range from 1 to 500 ng ml(-1) from 100 microl of human or dog plasma. The accuracy of the method was within 15% bias and the precision was lower than 15% for all tested concentration levels and in both matrices. The method is simple and the liquid-liquid extraction produces clean samples. This method was successfully applied to support the pharmacokinetics of a clinical trial in which orally applied Elacridar was used as a bioavailability enhancer.